Sonic Healthcare Limited
Sonic Healthcare Limited (SKHCF) Stock Competitors & Peer Comparison
See (SKHCF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SKHCF | $14.58 | +0.00% | 7.2B | 19.70 | $0.74 | +4.99% |
| LZAGF | $681.19 | -0.27% | 49B | 41.84 | $16.67 | +0.34% |
| WUXAY | $16.95 | +0.00% | 48.4B | 17.47 | $0.97 | +1.08% |
| LZAGY | $65.33 | -5.68% | 48.1B | 40.47 | $1.67 | +0.64% |
| WUXIF | $15.00 | +8.07% | 44.8B | 15.46 | $0.97 | +1.55% |
| ERFSF | $82.47 | +2.42% | 14.8B | 28.09 | $3.01 | +0.85% |
| BMXMF | $115.00 | +9.10% | 13.6B | 29.19 | $3.94 | +0.89% |
| SKHHY | $14.44 | -3.21% | 7.2B | 18.72 | $0.78 | +5.03% |
| HNGZY | $4.00 | +0.00% | 6.2B | 26.67 | $0.15 | +0.72% |
| DSRLF | $71.94 | +7.37% | 3.9B | 21.65 | $3.35 | +1.86% |
Stock Comparison
SKHCF vs LZAGF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, LZAGF has a market cap of 49B. Regarding current trading prices, SKHCF is priced at $14.58, while LZAGF trades at $681.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas LZAGF's P/E ratio is 41.84. In terms of profitability, SKHCF's ROE is +0.06%, compared to LZAGF's ROE of +0.10%. Regarding short-term risk, SKHCF is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check LZAGF's competition here
SKHCF vs WUXAY Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, WUXAY has a market cap of 48.4B. Regarding current trading prices, SKHCF is priced at $14.58, while WUXAY trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas WUXAY's P/E ratio is 17.47. In terms of profitability, SKHCF's ROE is +0.06%, compared to WUXAY's ROE of +0.28%. Regarding short-term risk, SKHCF and WUXAY have similar daily volatility (0.00).Check WUXAY's competition here
SKHCF vs LZAGY Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, LZAGY has a market cap of 48.1B. Regarding current trading prices, SKHCF is priced at $14.58, while LZAGY trades at $65.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas LZAGY's P/E ratio is 40.47. In terms of profitability, SKHCF's ROE is +0.06%, compared to LZAGY's ROE of +0.10%. Regarding short-term risk, SKHCF is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check LZAGY's competition here
SKHCF vs WUXIF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, WUXIF has a market cap of 44.8B. Regarding current trading prices, SKHCF is priced at $14.58, while WUXIF trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas WUXIF's P/E ratio is 15.46. In terms of profitability, SKHCF's ROE is +0.06%, compared to WUXIF's ROE of +0.28%. Regarding short-term risk, SKHCF and WUXIF have similar daily volatility (0.00).Check WUXIF's competition here
SKHCF vs ERFSF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, ERFSF has a market cap of 14.8B. Regarding current trading prices, SKHCF is priced at $14.58, while ERFSF trades at $82.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas ERFSF's P/E ratio is 28.09. In terms of profitability, SKHCF's ROE is +0.06%, compared to ERFSF's ROE of +0.12%. Regarding short-term risk, SKHCF is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check ERFSF's competition here
SKHCF vs BMXMF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, BMXMF has a market cap of 13.6B. Regarding current trading prices, SKHCF is priced at $14.58, while BMXMF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas BMXMF's P/E ratio is 29.19. In terms of profitability, SKHCF's ROE is +0.06%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, SKHCF and BMXMF have similar daily volatility (0.00).Check BMXMF's competition here
SKHCF vs SKHHY Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, SKHHY has a market cap of 7.2B. Regarding current trading prices, SKHCF is priced at $14.58, while SKHHY trades at $14.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas SKHHY's P/E ratio is 18.72. In terms of profitability, SKHCF's ROE is +0.06%, compared to SKHHY's ROE of +0.05%. Regarding short-term risk, SKHCF is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check SKHHY's competition here
SKHCF vs HNGZY Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, HNGZY has a market cap of 6.2B. Regarding current trading prices, SKHCF is priced at $14.58, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, SKHCF's ROE is +0.06%, compared to HNGZY's ROE of +0.04%. Regarding short-term risk, SKHCF is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check HNGZY's competition here
SKHCF vs DSRLF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, DSRLF has a market cap of 3.9B. Regarding current trading prices, SKHCF is priced at $14.58, while DSRLF trades at $71.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas DSRLF's P/E ratio is 21.65. In terms of profitability, SKHCF's ROE is +0.06%, compared to DSRLF's ROE of +0.12%. Regarding short-term risk, SKHCF is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check DSRLF's competition here
SKHCF vs VIMGF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, VIMGF has a market cap of 2.4B. Regarding current trading prices, SKHCF is priced at $14.58, while VIMGF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas VIMGF's P/E ratio is 64.29. In terms of profitability, SKHCF's ROE is +0.06%, compared to VIMGF's ROE of +0.05%. Regarding short-term risk, SKHCF is less volatile compared to VIMGF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check VIMGF's competition here
SKHCF vs GNTLF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, GNTLF has a market cap of 1.3B. Regarding current trading prices, SKHCF is priced at $14.58, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, SKHCF's ROE is +0.06%, compared to GNTLF's ROE of -1.85%. Regarding short-term risk, SKHCF and GNTLF have similar daily volatility (0.00).Check GNTLF's competition here
SKHCF vs MRCHF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, SKHCF is priced at $14.58, while MRCHF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas MRCHF's P/E ratio is 52.38. In terms of profitability, SKHCF's ROE is +0.06%, compared to MRCHF's ROE of +0.04%. Regarding short-term risk, SKHCF and MRCHF have similar daily volatility (0.00).Check MRCHF's competition here
SKHCF vs IDGXF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, IDGXF has a market cap of 298.6M. Regarding current trading prices, SKHCF is priced at $14.58, while IDGXF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas IDGXF's P/E ratio is 12.84. In terms of profitability, SKHCF's ROE is +0.06%, compared to IDGXF's ROE of +0.28%. Regarding short-term risk, SKHCF and IDGXF have similar daily volatility (0.00).Check IDGXF's competition here
SKHCF vs EDTXF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, EDTXF has a market cap of 293.4M. Regarding current trading prices, SKHCF is priced at $14.58, while EDTXF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas EDTXF's P/E ratio is -8.33. In terms of profitability, SKHCF's ROE is +0.06%, compared to EDTXF's ROE of +0.88%. Regarding short-term risk, SKHCF is less volatile compared to EDTXF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check EDTXF's competition here
SKHCF vs PFGTF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, PFGTF has a market cap of 181.1M. Regarding current trading prices, SKHCF is priced at $14.58, while PFGTF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas PFGTF's P/E ratio is -8.85. In terms of profitability, SKHCF's ROE is +0.06%, compared to PFGTF's ROE of -1.30%. Regarding short-term risk, SKHCF and PFGTF have similar daily volatility (0.00).Check PFGTF's competition here
SKHCF vs AMCY Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, SKHCF is priced at $14.58, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas AMCY's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to AMCY's ROE of N/A. Regarding short-term risk, SKHCF and AMCY have similar daily volatility (0.00).Check AMCY's competition here
SKHCF vs NNGRF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, SKHCF is priced at $14.58, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, SKHCF's ROE is +0.06%, compared to NNGRF's ROE of -0.05%. Regarding short-term risk, SKHCF and NNGRF have similar daily volatility (0.00).Check NNGRF's competition here
SKHCF vs DIUXF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, DIUXF has a market cap of 141.3M. Regarding current trading prices, SKHCF is priced at $14.58, while DIUXF trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas DIUXF's P/E ratio is -83.50. In terms of profitability, SKHCF's ROE is +0.06%, compared to DIUXF's ROE of -0.04%. Regarding short-term risk, SKHCF is less volatile compared to DIUXF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check DIUXF's competition here
SKHCF vs CORBF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, CORBF has a market cap of 127.2M. Regarding current trading prices, SKHCF is priced at $14.58, while CORBF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas CORBF's P/E ratio is 2.71. In terms of profitability, SKHCF's ROE is +0.06%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, SKHCF and CORBF have similar daily volatility (0.00).Check CORBF's competition here
SKHCF vs LDXHF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, LDXHF has a market cap of 114.6M. Regarding current trading prices, SKHCF is priced at $14.58, while LDXHF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas LDXHF's P/E ratio is -15.01. In terms of profitability, SKHCF's ROE is +0.06%, compared to LDXHF's ROE of -1.21%. Regarding short-term risk, SKHCF is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check LDXHF's competition here
SKHCF vs THOXF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, THOXF has a market cap of 73.8M. Regarding current trading prices, SKHCF is priced at $14.58, while THOXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas THOXF's P/E ratio is -7.45. In terms of profitability, SKHCF's ROE is +0.06%, compared to THOXF's ROE of -1.67%. Regarding short-term risk, SKHCF is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check THOXF's competition here
SKHCF vs TIHE Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, SKHCF is priced at $14.58, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas TIHE's P/E ratio is 0.32. In terms of profitability, SKHCF's ROE is +0.06%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, SKHCF and TIHE have similar daily volatility (0.00).Check TIHE's competition here
SKHCF vs BIOGF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, SKHCF is priced at $14.58, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, SKHCF's ROE is +0.06%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, SKHCF and BIOGF have similar daily volatility (0.00).Check BIOGF's competition here
SKHCF vs PCNEF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, SKHCF is priced at $14.58, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, SKHCF's ROE is +0.06%, compared to PCNEF's ROE of -0.05%. Regarding short-term risk, SKHCF is less volatile compared to PCNEF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check PCNEF's competition here
SKHCF vs BMKDF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, BMKDF has a market cap of 45.9M. Regarding current trading prices, SKHCF is priced at $14.58, while BMKDF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas BMKDF's P/E ratio is -43.70. In terms of profitability, SKHCF's ROE is +0.06%, compared to BMKDF's ROE of -1.53%. Regarding short-term risk, SKHCF is less volatile compared to BMKDF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check BMKDF's competition here
SKHCF vs BIOQ Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, BIOQ has a market cap of 33M. Regarding current trading prices, SKHCF is priced at $14.58, while BIOQ trades at $36.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas BIOQ's P/E ratio is 15.59. In terms of profitability, SKHCF's ROE is +0.06%, compared to BIOQ's ROE of +0.01%. Regarding short-term risk, SKHCF and BIOQ have similar daily volatility (0.00).Check BIOQ's competition here
SKHCF vs LDDD Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, LDDD has a market cap of 28M. Regarding current trading prices, SKHCF is priced at $14.58, while LDDD trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas LDDD's P/E ratio is -93.40. In terms of profitability, SKHCF's ROE is +0.06%, compared to LDDD's ROE of -0.28%. Regarding short-term risk, SKHCF and LDDD have similar daily volatility (0.00).Check LDDD's competition here
SKHCF vs SNANF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, SNANF has a market cap of 27.3M. Regarding current trading prices, SKHCF is priced at $14.58, while SNANF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas SNANF's P/E ratio is -11.95. In terms of profitability, SKHCF's ROE is +0.06%, compared to SNANF's ROE of -10.44%. Regarding short-term risk, SKHCF and SNANF have similar daily volatility (0.00).Check SNANF's competition here
SKHCF vs CLIFF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, CLIFF has a market cap of 23.1M. Regarding current trading prices, SKHCF is priced at $14.58, while CLIFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas CLIFF's P/E ratio is -2.25. In terms of profitability, SKHCF's ROE is +0.06%, compared to CLIFF's ROE of -0.12%. Regarding short-term risk, SKHCF and CLIFF have similar daily volatility (0.00).Check CLIFF's competition here
SKHCF vs ANPCY Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, ANPCY has a market cap of 22M. Regarding current trading prices, SKHCF is priced at $14.58, while ANPCY trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas ANPCY's P/E ratio is -0.10. In terms of profitability, SKHCF's ROE is +0.06%, compared to ANPCY's ROE of -0.90%. Regarding short-term risk, SKHCF is less volatile compared to ANPCY. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check ANPCY's competition here
SKHCF vs PCHM Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, PCHM has a market cap of 22M. Regarding current trading prices, SKHCF is priced at $14.58, while PCHM trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas PCHM's P/E ratio is -0.02. In terms of profitability, SKHCF's ROE is +0.06%, compared to PCHM's ROE of +0.25%. Regarding short-term risk, SKHCF is less volatile compared to PCHM. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check PCHM's competition here
SKHCF vs VILGF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, SKHCF is priced at $14.58, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas VILGF's P/E ratio is -0.30. In terms of profitability, SKHCF's ROE is +0.06%, compared to VILGF's ROE of N/A. Regarding short-term risk, SKHCF and VILGF have similar daily volatility (0.00).Check VILGF's competition here
SKHCF vs JMPHF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, JMPHF has a market cap of 15.2M. Regarding current trading prices, SKHCF is priced at $14.58, while JMPHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas JMPHF's P/E ratio is 8.00. In terms of profitability, SKHCF's ROE is +0.06%, compared to JMPHF's ROE of +0.31%. Regarding short-term risk, SKHCF and JMPHF have similar daily volatility (0.00).Check JMPHF's competition here
SKHCF vs ABDXF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, ABDXF has a market cap of 13.3M. Regarding current trading prices, SKHCF is priced at $14.58, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, SKHCF's ROE is +0.06%, compared to ABDXF's ROE of -0.45%. Regarding short-term risk, SKHCF and ABDXF have similar daily volatility (0.00).Check ABDXF's competition here
SKHCF vs IZOZF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, IZOZF has a market cap of 12.4M. Regarding current trading prices, SKHCF is priced at $14.58, while IZOZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas IZOZF's P/E ratio is -9.00. In terms of profitability, SKHCF's ROE is +0.06%, compared to IZOZF's ROE of +0.48%. Regarding short-term risk, SKHCF is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check IZOZF's competition here
SKHCF vs IDXG Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, IDXG has a market cap of 9.1M. Regarding current trading prices, SKHCF is priced at $14.58, while IDXG trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas IDXG's P/E ratio is 2.27. In terms of profitability, SKHCF's ROE is +0.06%, compared to IDXG's ROE of +4.85%. Regarding short-term risk, SKHCF is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check IDXG's competition here
SKHCF vs MXDHF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, SKHCF is priced at $14.58, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, SKHCF's ROE is +0.06%, compared to MXDHF's ROE of +5.17%. Regarding short-term risk, SKHCF and MXDHF have similar daily volatility (0.00).Check MXDHF's competition here
SKHCF vs ICBU Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, ICBU has a market cap of 6.4M. Regarding current trading prices, SKHCF is priced at $14.58, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas ICBU's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to ICBU's ROE of -0.22%. Regarding short-term risk, SKHCF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check ICBU's competition here
SKHCF vs IMMVF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, IMMVF has a market cap of 6.1M. Regarding current trading prices, SKHCF is priced at $14.58, while IMMVF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas IMMVF's P/E ratio is -0.50. In terms of profitability, SKHCF's ROE is +0.06%, compared to IMMVF's ROE of -5.64%. Regarding short-term risk, SKHCF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check IMMVF's competition here
SKHCF vs SQIDF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, SKHCF is priced at $14.58, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, SKHCF's ROE is +0.06%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, SKHCF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check SQIDF's competition here
SKHCF vs PMSNF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, PMSNF has a market cap of 5.2M. Regarding current trading prices, SKHCF is priced at $14.58, while PMSNF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas PMSNF's P/E ratio is -1.00. In terms of profitability, SKHCF's ROE is +0.06%, compared to PMSNF's ROE of +0.34%. Regarding short-term risk, SKHCF and PMSNF have similar daily volatility (0.00).Check PMSNF's competition here
SKHCF vs AVCRF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, AVCRF has a market cap of 4.8M. Regarding current trading prices, SKHCF is priced at $14.58, while AVCRF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas AVCRF's P/E ratio is -4.77. In terms of profitability, SKHCF's ROE is +0.06%, compared to AVCRF's ROE of -0.95%. Regarding short-term risk, SKHCF is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check AVCRF's competition here
SKHCF vs VRCDF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, VRCDF has a market cap of 4.5M. Regarding current trading prices, SKHCF is priced at $14.58, while VRCDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas VRCDF's P/E ratio is -0.10. In terms of profitability, SKHCF's ROE is +0.06%, compared to VRCDF's ROE of -1.93%. Regarding short-term risk, SKHCF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check VRCDF's competition here
SKHCF vs RNVA Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, SKHCF is priced at $14.58, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas RNVA's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, SKHCF and RNVA have similar daily volatility (0.00).Check RNVA's competition here
SKHCF vs TDSGF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, TDSGF has a market cap of 4M. Regarding current trading prices, SKHCF is priced at $14.58, while TDSGF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas TDSGF's P/E ratio is -4.00. In terms of profitability, SKHCF's ROE is +0.06%, compared to TDSGF's ROE of -9.19%. Regarding short-term risk, SKHCF and TDSGF have similar daily volatility (0.00).Check TDSGF's competition here
SKHCF vs ANPCF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, ANPCF has a market cap of 3.4M. Regarding current trading prices, SKHCF is priced at $14.58, while ANPCF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas ANPCF's P/E ratio is -0.15. In terms of profitability, SKHCF's ROE is +0.06%, compared to ANPCF's ROE of -0.90%. Regarding short-term risk, SKHCF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check ANPCF's competition here
SKHCF vs IBXXF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, IBXXF has a market cap of 3.3M. Regarding current trading prices, SKHCF is priced at $14.58, while IBXXF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas IBXXF's P/E ratio is -1.50. In terms of profitability, SKHCF's ROE is +0.06%, compared to IBXXF's ROE of +1.43%. Regarding short-term risk, SKHCF and IBXXF have similar daily volatility (0.00).Check IBXXF's competition here
SKHCF vs IVRO Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, IVRO has a market cap of 1.8M. Regarding current trading prices, SKHCF is priced at $14.58, while IVRO trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas IVRO's P/E ratio is -0.80. In terms of profitability, SKHCF's ROE is +0.06%, compared to IVRO's ROE of +0.06%. Regarding short-term risk, SKHCF is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check IVRO's competition here
SKHCF vs CHHL Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, CHHL has a market cap of 1.8M. Regarding current trading prices, SKHCF is priced at $14.58, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas CHHL's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, SKHCF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check CHHL's competition here
SKHCF vs SLDX Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, SLDX has a market cap of 1.4M. Regarding current trading prices, SKHCF is priced at $14.58, while SLDX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas SLDX's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to SLDX's ROE of +0.17%. Regarding short-term risk, SKHCF and SLDX have similar daily volatility (0.00).Check SLDX's competition here
SKHCF vs DIGP Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, SKHCF is priced at $14.58, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas DIGP's P/E ratio is -1.04. In terms of profitability, SKHCF's ROE is +0.06%, compared to DIGP's ROE of +1.19%. Regarding short-term risk, SKHCF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check DIGP's competition here
SKHCF vs IDTA Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, IDTA has a market cap of 1M. Regarding current trading prices, SKHCF is priced at $14.58, while IDTA trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas IDTA's P/E ratio is 12.40. In terms of profitability, SKHCF's ROE is +0.06%, compared to IDTA's ROE of +0.13%. Regarding short-term risk, SKHCF and IDTA have similar daily volatility (0.00).Check IDTA's competition here
SKHCF vs EPGNF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, EPGNF has a market cap of 982.2K. Regarding current trading prices, SKHCF is priced at $14.58, while EPGNF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas EPGNF's P/E ratio is -0.30. In terms of profitability, SKHCF's ROE is +0.06%, compared to EPGNF's ROE of +0.03%. Regarding short-term risk, SKHCF and EPGNF have similar daily volatility (0.00).Check EPGNF's competition here
SKHCF vs RSHN Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, RSHN has a market cap of 857.6K. Regarding current trading prices, SKHCF is priced at $14.58, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas RSHN's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, SKHCF is less volatile compared to RSHN. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check RSHN's competition here
SKHCF vs SZLSF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, SZLSF has a market cap of 630K. Regarding current trading prices, SKHCF is priced at $14.58, while SZLSF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas SZLSF's P/E ratio is -0.04. In terms of profitability, SKHCF's ROE is +0.06%, compared to SZLSF's ROE of +4.82%. Regarding short-term risk, SKHCF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check SZLSF's competition here
SKHCF vs SCRSF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, SCRSF has a market cap of 600.3K. Regarding current trading prices, SKHCF is priced at $14.58, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas SCRSF's P/E ratio is -0.20. In terms of profitability, SKHCF's ROE is +0.06%, compared to SCRSF's ROE of +2.02%. Regarding short-term risk, SKHCF and SCRSF have similar daily volatility (0.00).Check SCRSF's competition here
SKHCF vs NSTM Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, NSTM has a market cap of 483.5K. Regarding current trading prices, SKHCF is priced at $14.58, while NSTM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas NSTM's P/E ratio is 0.20. In terms of profitability, SKHCF's ROE is +0.06%, compared to NSTM's ROE of -0.83%. Regarding short-term risk, SKHCF and NSTM have similar daily volatility (0.00).Check NSTM's competition here
SKHCF vs MBGNF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, MBGNF has a market cap of 101.8K. Regarding current trading prices, SKHCF is priced at $14.58, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas MBGNF's P/E ratio is -0.59. In terms of profitability, SKHCF's ROE is +0.06%, compared to MBGNF's ROE of +0.26%. Regarding short-term risk, SKHCF is less volatile compared to MBGNF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check MBGNF's competition here
SKHCF vs NVTAQ Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, SKHCF is priced at $14.58, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, SKHCF's ROE is +0.06%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, SKHCF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check NVTAQ's competition here
SKHCF vs ARYC Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, SKHCF is priced at $14.58, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas ARYC's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, SKHCF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check ARYC's competition here
SKHCF vs HCLC Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, SKHCF is priced at $14.58, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas HCLC's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, SKHCF and HCLC have similar daily volatility (0.00).Check HCLC's competition here
SKHCF vs MEDD Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, MEDD has a market cap of 63.8K. Regarding current trading prices, SKHCF is priced at $14.58, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas MEDD's P/E ratio is -0.02. In terms of profitability, SKHCF's ROE is +0.06%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, SKHCF is less volatile compared to MEDD. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check MEDD's competition here
SKHCF vs IHTI Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, SKHCF is priced at $14.58, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas IHTI's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, SKHCF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check IHTI's competition here
SKHCF vs TOMDF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, SKHCF is priced at $14.58, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas TOMDF's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, SKHCF and TOMDF have similar daily volatility (0.00).Check TOMDF's competition here
SKHCF vs CGNH Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, SKHCF is priced at $14.58, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas CGNH's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, SKHCF and CGNH have similar daily volatility (0.00).Check CGNH's competition here
SKHCF vs ABMC Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, SKHCF is priced at $14.58, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas ABMC's P/E ratio is 0.01. In terms of profitability, SKHCF's ROE is +0.06%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, SKHCF and ABMC have similar daily volatility (0.00).Check ABMC's competition here
SKHCF vs CYPS Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, CYPS has a market cap of 4.1K. Regarding current trading prices, SKHCF is priced at $14.58, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas CYPS's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to CYPS's ROE of N/A. Regarding short-term risk, SKHCF and CYPS have similar daily volatility (0.00).Check CYPS's competition here
SKHCF vs RGDXQ Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, SKHCF is priced at $14.58, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, SKHCF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check RGDXQ's competition here
SKHCF vs DMTKQ Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, SKHCF is priced at $14.58, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas DMTKQ's P/E ratio is -0.00. In terms of profitability, SKHCF's ROE is +0.06%, compared to DMTKQ's ROE of -1.06%. Regarding short-term risk, SKHCF and DMTKQ have similar daily volatility (0.00).Check DMTKQ's competition here
SKHCF vs MEDVF Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, MEDVF has a market cap of 2.7K. Regarding current trading prices, SKHCF is priced at $14.58, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas MEDVF's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to MEDVF's ROE of +2.13%. Regarding short-term risk, SKHCF is less volatile compared to MEDVF. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check MEDVF's competition here
SKHCF vs GWHP Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, SKHCF is priced at $14.58, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas GWHP's P/E ratio is -0.00. In terms of profitability, SKHCF's ROE is +0.06%, compared to GWHP's ROE of +6.19%. Regarding short-term risk, SKHCF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check GWHP's competition here
SKHCF vs ROSGQ Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, SKHCF is priced at $14.58, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, SKHCF and ROSGQ have similar daily volatility (0.00).Check ROSGQ's competition here
SKHCF vs BIOCQ Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, SKHCF is priced at $14.58, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas BIOCQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, SKHCF and BIOCQ have similar daily volatility (0.00).Check BIOCQ's competition here
SKHCF vs HTGMQ Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, SKHCF is priced at $14.58, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, SKHCF and HTGMQ have similar daily volatility (0.00).Check HTGMQ's competition here
SKHCF vs OPGX Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, OPGX has a market cap of 17. Regarding current trading prices, SKHCF is priced at $14.58, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas OPGX's P/E ratio is -0.00. In terms of profitability, SKHCF's ROE is +0.06%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, SKHCF is less volatile compared to OPGX. This indicates potentially lower risk in terms of short-term price fluctuations for SKHCF.Check OPGX's competition here
SKHCF vs BGNX Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, BGNX has a market cap of 0. Regarding current trading prices, SKHCF is priced at $14.58, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas BGNX's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to BGNX's ROE of N/A. Regarding short-term risk, SKHCF and BGNX have similar daily volatility (0.00).Check BGNX's competition here
SKHCF vs AGHC Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, AGHC has a market cap of 0. Regarding current trading prices, SKHCF is priced at $14.58, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas AGHC's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, SKHCF and AGHC have similar daily volatility (0.00).Check AGHC's competition here
SKHCF vs EPGNY Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, SKHCF is priced at $14.58, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, SKHCF's ROE is +0.06%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, SKHCF and EPGNY have similar daily volatility (0.00).Check EPGNY's competition here
SKHCF vs MRPS Comparison April 2026
SKHCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKHCF stands at 7.2B. In comparison, MRPS has a market cap of 0. Regarding current trading prices, SKHCF is priced at $14.58, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKHCF currently has a P/E ratio of 19.70, whereas MRPS's P/E ratio is N/A. In terms of profitability, SKHCF's ROE is +0.06%, compared to MRPS's ROE of N/A. Regarding short-term risk, SKHCF and MRPS have similar daily volatility (0.00).Check MRPS's competition here